We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+15.32%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.02B
AUM Growth
+$175M
Cap. Flow
-$2.02B
Cap. Flow %
-40.15%
Top 10 Hldgs %
37.55%
Holding
141
New
17
Increased
15
Reduced
22
Closed
12

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$70.1M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$58M
3
RVMD icon
Revolution Medicines
RVMD
+$44M
4
LRMR icon
Larimar Therapeutics
LRMR
+$27.8M
5
VERV
Verve Therapeutics
VERV
+$23.9M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$98.4M
2
AHCO icon
AdaptHealth
AHCO
+$60.2M
3
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$59M
4
GKOS icon
Glaukos
GKOS
+$53.6M
5
DAWN
Day One Biopharmaceuticals
DAWN
+$52.7M

Sector Composition

Rank Sector Weight
1 Healthcare 53.48%
2 Financials 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNTE
76
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$2.99M 0.06%
250,000
– –
PROF
77
Profound Medical
PROF
$266M
$2.96M 0.06%
732,543
-981,254
-57% -$6.62M
NYXH
78
Nyxoah
NYXH
$140M
$2.87M 0.06%
455,262
– –
ONCR
79
DELISTED
Oncorus, Inc.
ONCR
$2.68M 0.05%
3,148,977
– –
AFIB
80
DELISTED
Acutus Medical Inc
AFIB
$2.33M 0.05%
2,651,667
+3,281
+0.1% +$3.97K
DCTH icon
81
Delcath Systems
DCTH
$412M
$1.55M 0.03%
486,068
-13,932
-3% -$56.4K
CMAXW
82
DELISTED
CareMax, Inc. Warrant
CMAXW
$1.26M 0.03%
672,000
– –
TOIIW
83
The Oncology Institute Warrant
TOIIW
$691K 0.01%
1,250,000
– –
MDVL
84
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$649K 0.01%
16,733
– –
BFLY.WS
85
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$616K 0.01%
733,333
– –
NUVB icon
86
Nuvation Bio
NUVB
$2.32B
$550K 0.01%
+245,360
New +$701K
ROIVW
87
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$390K 0.01%
1,000,000
– –
CABA icon
88
Cabaletta Bio
CABA
$444M
$302K 0.01%
464,252
– –
QSIAW
89
DELISTED
Quantum-Si Inc Warrant
QSIAW
$177K ﹤0.01%
333,333
– –
SLGCW
90
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$53K ﹤0.01%
120,000
– –
PKBOW
91
DELISTED
Peak Bio, Inc. Warrant
PKBOW
$45K ﹤0.01%
362,500
– –
NUVB.WS
92
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$33K ﹤0.01%
166,666
– –
SRZNW icon
93
Surrozen Inc Warrant
SRZNW
$75.6K
$31K ﹤0.01%
166,666
– –
TLSIW icon
94
TriSalus Life Sciences Warrant
TLSIW
$25.5M
$20K ﹤0.01%
333,333
– –
EUCRW
95
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$13K ﹤0.01%
333,333
– –
SNRHW
96
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$10K ﹤0.01%
500,000
– –
REVHW
97
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$9K ﹤0.01%
200,000
– –
OHPAW
98
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$7K ﹤0.01%
125,000
– –
SRSAW
99
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$7K ﹤0.01%
333,333
– –
TMPMW
100
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$7K ﹤0.01%
250,000
– –
1 2 3
4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2022 Portfolio in Review

As of Q3 2022, Deerfield Management held 141 positions worth $5.02B, up 3.6% from $4.85B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Deerfield Management withdrew a net $2.02B in Q3 2022, closing 12 positions and reducing 22 holdings. Its most notable exit was Glaukos, an estimated $53.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 51% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Biogen worth $88.1M.

  • Deerfield Management's largest Q3 2022 buy was Biogen: 330,000 shares worth $88.1M.
  • Deerfield Management added most to Revolution Medicines in Q3 2022, an estimated $44M increase.
  • Deerfield Management's biggest Q3 2022 reduction was Viatris, cutting an estimated $98.4M.
  • Deerfield Management fully exited Glaukos in Q3 2022, selling an estimated $53.6M.
  • Deerfield Management's ten largest holdings make up 38% of its $5.02B portfolio in Q3 2022.
  • Deerfield Management opened 17 new positions and closed 12 in Q3 2022.
  • Deerfield Management's portfolio value rose 3.6% quarter-over-quarter to $5.02B.

Based on Deerfield Management's 13F filing for Q3 2022, filed 14 Nov 2022.